Home › Agent Hub › Agent Tools › Part D coverage by drug › Amlodipine / Atorvastatin
Agent Tools
Amlodipine / Atorvastatin is a generic drug. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 4,477 of 5,492 Medicare Part D and Medicare Advantage drug plans (81.5%) list Amlodipine / Atorvastatin on their formulary, across 161 of 286 formularies. The most common placement is tier 1 (3,586 plans, 80.1% of those covering it). 0 of the covering plans require prior authorization (0%), 12 step therapy and 2,261 a quantity limit.
4,246 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $0, 4,059 of them $0; 231 charge coinsurance instead — median 25% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 4,446 of 5,496 plans covered it (80.9%); 2027: 4,477 of 5,492 (81.5%).
Of 4,367 plans offered in both years, 54 added it to the formulary and 56 dropped it.
Among plans covering it both years, 90 moved it to a higher tier and 910 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 3,586 |
| Tier 2 | 247 |
| Tier 3 | 127 |
| Tier 4 | 19 |
| Tier 5 | 3 |
| Tier 6 | 495 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 133 of 323 | 41.2% | 0% |
| Medicare Advantage with drugs (MA-PD) | 2,634 of 3,200 | 82.3% | 0% |
| Special needs plans (SNP) | 1,710 of 1,969 | 86.8% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 744 of 846 | Tier 1 | 0 |
| UnitedHealthcare | 830 of 830 | Tier 1 | 0 |
| Devoted Health | 728 of 728 | Tier 1 | 0 |
| Aetna Medicare | 631 of 631 | Tier 1 | 0 |
| Wellcare | 234 of 268 | Tier 6 | 0 |
| HealthSpring | 186 of 226 | Tier 1 | 0 |
| Kaiser Permanente | 0 of 112 | No tier listed | 0 |
| SCAN Health Plan | 83 of 83 | Tier 2 | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 12 of 80 | Tier 2 | 0 |
| Alignment Health Plan | 77 of 77 | Tier 6 | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 1 | 0 |
| Wellpoint | 63 of 63 | Tier 1 | 0 |
| Priority Health Medicare | 0 of 40 | No tier listed | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 1 | 0 |
| Zing Health | 36 of 36 | Tier 1 | 0 |
| Capital Blue Cross | 8 of 35 | Tier 3 | 0 |
| Prominence Health Plan | 0 of 29 | No tier listed | 0 |
| Medica | 1 of 27 | Tier 2 | 0 |
| Anthem HealthKeepers | 26 of 26 | Tier 1 | 0 |
| Blue Cross Blue Shield of Michigan | 0 of 26 | No tier listed | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 103 of 114 | 90.4% |
| Alaska | 4 of 9 | 44.4% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 130 of 147 | 88.4% |
| Arkansas | 75 of 85 | 88.2% |
| California | 331 of 397 | 83.4% |
| Colorado | 86 of 106 | 81.1% |
| Connecticut | 47 of 54 | 87% |
| Delaware | 31 of 43 | 72.1% |
| District of Columbia | 8 of 12 | 66.7% |
| Florida | 441 of 545 | 80.9% |
| Georgia | 131 of 149 | 87.9% |
| Guam | 1 of 1 | 100% |
| Hawaii | 32 of 50 | 64% |
| Idaho | 30 of 45 | 66.7% |
| Illinois | 124 of 132 | 93.9% |
| Indiana | 128 of 138 | 92.8% |
| Iowa | 47 of 64 | 73.4% |
| Kansas | 76 of 84 | 90.5% |
| Kentucky | 115 of 121 | 95% |
| Louisiana | 116 of 125 | 92.8% |
| Maine | 45 of 52 | 86.5% |
| Maryland | 21 of 49 | 42.9% |
| Massachusetts | 55 of 89 | 61.8% |
| Michigan | 91 of 182 | 50% |
| Minnesota | 31 of 63 | 49.2% |
| Mississippi | 98 of 104 | 94.2% |
| Missouri | 158 of 170 | 92.9% |
| Montana | 20 of 27 | 74.1% |
| Nebraska | 36 of 51 | 70.6% |
| Nevada | 82 of 100 | 82% |
| New Hampshire | 20 of 25 | 80% |
| New Jersey | 65 of 73 | 89% |
| New Mexico | 59 of 68 | 86.8% |
| New York | 179 of 215 | 83.3% |
| North Carolina | 145 of 176 | 82.4% |
| North Dakota | 11 of 26 | 42.3% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 140 of 171 | 81.9% |
| Oklahoma | 69 of 81 | 85.2% |
| Oregon | 75 of 92 | 81.5% |
| Pennsylvania | 176 of 323 | 54.5% |
| Puerto Rico | 62 of 64 | 96.9% |
| Rhode Island | 20 of 29 | 69% |
| South Carolina | 74 of 89 | 83.1% |
| South Dakota | 13 of 30 | 43.3% |
| Tennessee | 147 of 156 | 94.2% |
| Texas | 370 of 407 | 90.9% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 47 of 53 | 88.7% |
| Vermont | 7 of 14 | 50% |
| Virginia | 128 of 144 | 88.9% |
| Washington | 87 of 114 | 76.3% |
| West Virginia | 49 of 69 | 71% |
| Wisconsin | 59 of 96 | 61.5% |
| Wyoming | 6 of 13 | 46.2% |
Medicare Part D paid for 256,439 30-day fills of Amlodipine / Atorvastatin in 2024 for about 26,782 enrollees, at an average total cost of $69.43 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Amlodipine / Atorvastatin and the rest of a client's list on every plan in their county.
Estimate Amlodipine / Atorvastatin costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.